Why is Shree Ganesh Bio falling/rising?

As of 12-Aug, Shree Ganesh Biotech India Ltd's stock price is currently at Rs 0.80, reflecting an increase of Rs 0.02 or 2.56%. The stock has shown a mixed performance in recent periods, with a 1-week return of +1.27%, which is a positive sign compared to the Sensex's decline of -0.59%. However, over the longer term, the stock has struggled significantly, with a year-to-date return of -23.08% and a one-year return of -31.62%. Today's performance indicates that the stock has outperformed its sector by 3.02%, yet it remains close to its 52-week low, just 3.75% above it. The stock is also experiencing falling investor participation, with a notable decrease in delivery volume, which may indicate waning interest among investors. Additionally, the company faces challenges such as operating losses, a weak ability to service debt, and low profitability, which contribute to its classification as a strong sell.
In the broader market context, the stock's recent short-term performance contrasts with the benchmark, as it has managed to rise while the Sensex has declined. This short-term outperformance may be attributed to specific trading dynamics rather than a fundamental recovery, as the stock's long-term outlook remains concerning due to its significant losses and weak financial metrics. The overall market sentiment appears to be cautious, especially given the company's negative EBITDA and poor return on equity, which suggest that investors may be hesitant to commit to the stock despite its recent uptick.